Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -66.67% |
| Sep 30, 2020 | 3,114.29% |
| Jun 30, 2020 | -153.85% |
| Dec 31, 2018 | -63.32% |
| Sep 30, 2018 | 68.71% |
| Jun 30, 2018 | 316.67% |
| Dec 31, 2015 | -12.50% |
| Mar 31, 2015 | 111.76% |
| Dec 31, 2014 | -214.90% |
| Sep 30, 2014 | 260.70% |
| Jun 30, 2014 | 3,920.00% |
| Mar 31, 2014 | -50.00% |
| Dec 31, 2013 | 300.00% |
| Dec 31, 2012 | -107.14% |
| Sep 30, 2012 | 316.22% |
| Jun 30, 2012 | -71.54% |
| Mar 31, 2012 | 319.35% |
| Dec 31, 2011 | -91.60% |